PROTEOSTASIS THERAPEUTICS, INC. (60) | Intellectual Property (4)
Browse by Subcategory
Recent Contracts
-
License Agreement by and between Yumanity Therapeutics, Inc. and MIL 40, LLC dated as of February 28, 2022
(Filed With SEC on March 4, 2022)
-
License Agreement, by and between Yumanity Therapeutics, Inc. and MIL 40G LLC, dated as of February 5, 2020
(Filed With SEC on September 23, 2020)
-
Tangible Property and Exclusive Patent License Agreement, by and between Yumanity Therapeutics, Inc., Yumanity Holdings, LLC and Whitehead Institute for Biomedical Research, dated...
(Filed With SEC on September 23, 2020)
-
Technology Transfer and License Agreement between the Company and Genentech, Inc., dated December 13, 2018
(Filed With SEC on March 8, 2019)